摘要
目的:探讨组织蛋白酶B(cathepsin B,CatB)在脑胶质瘤中表达,为判断胶质瘤良恶性程度以对胶质瘤诊断、治疗及预后提供新思路、新方法。方法:2003年1月~2007年7月在我院神经外科住院的60例经手术病理检查证实的胶质瘤标本;另选颅脑损伤内减压手术切除的10例脑组织标本作为正常对照。采用免疫组织化学方法检测60例胶质瘤组织与10例正常脑组织中组织蛋白酶B表达情况,收集各病例的临床病理资料,用统计学软件SPPS10.0对实验结果进行分析。结果:60例胶质瘤组织中有49例CatB表达,阳性表达率为81.7%(P<0.05)。CatB的表达与患者的年龄、性别和肿瘤部位、大小、形状无关(P>0.05)。结论:CatB胶质瘤中表达水平明显高于正常对照组,说明CatB与胶质瘤的发病相关。
Objective: To study the expression of CatB in glioma. Methods: Sixty samples of glioma tissue and ten samples of normal human cerebral tissue surgically resected were collected;gliomas were confirmed by pathological diagnosis. The experssion of CatB was detected by immunohistochemistry. Results: The expression of CatB in 10 samples of normal cerebral tissues were negative . Of the 60 samples of glioma , 43(81.7%) showed positive CatB, The difference was significant (P〈0.05). CatB expression was not related with the patients age, sex and the size, location, sign of tumors (P〉0.05). Conclusion: The expression in glioma group is obviously higher than normar group. It is possible that CatB have some important effect on invasive growth of glioma tumor cell.
出处
《泸州医学院学报》
2009年第5期500-503,共4页
Journal of Luzhou Medical College